Please select the option that best describes you:
Topics:
Sarcoma • Medical Oncology
What systemic treatment do you utilize for patients with metastatic fibrosarcomatous DFSP that have progressed on imatinib?
Would you prefer doxorubicin based chemotherapy or are alternative TKIs useful in this scenario?
Answer from: Medical Oncologist at Academic Institution
Unfortunately, these fibrosarcomas do not respond well to other TKIs. Modest activity of standard STS chemotherapy.
Sign in or Register to read more